Craft
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
banner
Shanghai Haishun New Pharmaceutical Packaging financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.

Stock Price

¥14

2024-10-29

Market Capitalization

¥2.7 B

2024-10-29

Revenue

¥1.1 B

FY, 2025

CreditSafe Score

?
Score changed on Jun 11, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn more

Financial Statements

CNYFY, 2018FY, 2019FY, 2020FY, 2021FY, 2022FY, 2023FY, 2024FY, 2025
Revenue502.2M613.2M704.7M846.3M991.8M995.3M1.1B1.1B
Cost of goods sold341.5M427.5M470.0M609.8M740.9M712.7M813.2M857.6M
Gross profit162.3M189.1M238.7M241.5M263.2M297.7M318.3M234.3M
Gross profit margin, %30.8%33.9%28.5%26.5%29.9%28.5%22.0%
Operating expense total38.5M92.2M111.2M111.1M106.4M135.2M131.3M117.1M
Depreciation and amortization55.6M33.0M34.6M36.7M42.6M48.7M65.4M141.5M
EBITDA123.8M96.9M147.1M143.5M155.3M169.7M193.7M136.6M
EBITDA margin, %15.8%20.9%17.0%15.7%17.1%17.4%12.8%
EBIT69.5M63.5M113.1M107.3M114.5M121.1M120.6M(17.5M)
EBIT margin, %10.4%16.1%12.7%11.5%12.2%10.8%-1.6%
Interest income344.0K956.0K586.0K2.5M7.4M12.0M12.6M1.9M
Interest expense2.0M7.2M8.9M9.2M5.3M11.5M10.1M12.5M
Pre tax profit77.0M73.1M118.7M117.4M122.9M109.0M97.8M(15.1M)
Income tax expense12.6M7.4M13.3M8.4M13.1M14.6M16.9M692.0K
Net Income64.4M65.7M105.4M109.0M109.9M94.3M80.9M(15.8M)

Footer menu